Sandoz Group AG - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
SDZNY Over the counter 2834 www.sandoz.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sandoz Group AG

mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide - Sep 18th, 2026 4:28 am
“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy - Sep 9th, 2026 5:19 am
GRFS or SDZNY: Which Is the Better Value Stock Right Now? - Sep 8th, 2026 9:40 am
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris - Aug 31st, 2026 9:10 am
3 Generic Drug Stocks to Watch Amid Improving Industry Trends - Aug 27th, 2026 11:06 am
AstraZeneca scores in lung cancer; Sandoz inks a China deal - Aug 18th, 2026 5:13 am
Sandoz targets industry patent void with $322m Henlius deal - Aug 17th, 2026 5:47 am
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform - Aug 16th, 2026 10:08 pm
Sandoz Inc. agrees to $469M settlement in generic drug price-fixing case, Tong says - Aug 6th, 2026 4:00 am
AG Drummond announces $469 million settlement with Sandoz over drug pricing scheme - Aug 5th, 2026 11:44 am
Sandoz Group AG (SDZNY) (H1 2026) Earnings Call Highlights: Biosimilar Growth Drives 5% Sales ... - Aug 5th, 2026 9:01 am
South Dakota to receive nearly $1 million in Sandoz settlement - Aug 5th, 2026 3:15 am
Sandoz Group (SWX:SDZ) Settles US Drug Pricing Cases And Wins Brazil Semaglutide Approval - Aug 4th, 2026 8:49 pm